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DObjectives: Neonates with hypoplastic left heart syndrome have significant hemodynamic threats to cerebral
perfusion and are at risk of reduced neurodevelopmental performance. We hypothesized that cerebral hypoxia,
detectable by near-infrared spectroscopy in the early postoperative period, would be related to later neurodeve-
lopmental performance.
Methods: The study population was a sequential cohort of patients who had undergone stage 1 palliation of
hypoplastic left heart syndrome under standard conditions, including neonatal perioperative monitoring with
cerebral near-infrared spectroscopy, and who had undergone a neurodevelopmental assessment at age 4 to 5
years. The neonatal demographic and 48-hour perioperative hemodynamic parameters, including cerebral oxy-
gen saturation, were tested for their relationship to 4 domains of neurodevelopmental performance, including
visual-motor integration in childhood in univariate and multivariate models. The neurodevelopmental scores
were classified as low if less than 85 (1 standard deviation) and abnormal if less than 70 (2 standard
deviations).
Results: For the 51 patients in the surgical cohort, the early survival was 94%, the cumulative survival was 86%,
and the neurodevelopmental assessment was completed by 21 (48%) of the survivors, without evidence of an
ascertainment bias. At the test age of 56.3  5.5 months, the composite neurodevelopmental index, constructed
from equally weighted measures in 4 domains, was 97.6 9.6, not different from the age-based norms, with 3 of
21 in the low range and none abnormal. The mean visual-motor integration was 93.4 14, slightly less than the
population norm (P< .05), with 2 of 21 having low scores and 1 abnormal scores. In patients with low to
abnormal visual-motor integration, the perioperative stage 1 palliation cerebral oxygenation saturation was sig-
nificantly lower (63.6  8.1 vs 67.8  8.1, P<.05). Two patients had discrete embolic strokes after their initial
hospitalization; the occurrence of late stroke reduced the visual-motor integration performance but was not
related to the early cerebral oxygen saturation. Nonlinear relationships of cerebral oxygen saturation to the neu-
rodevelopmental measures found cerebral oxygen saturation thresholds of 49% to 62%. The hours at a cerebral
oxygen saturation less than 45% and 55%were related to low visual-motor integration and neurodevelopmental
index scores in the univariate and multivariate models. A multivariate model of age and weight at stage 1 pal-
liation, cerebral oxygen saturation, arterial oxygen saturation, cardiopulmonary bypass and deep hypothermic
circulatory arrest times, and later stroke predicted visual-motor integration to an important degree
(R2 ¼ 0.53, P<.001). The actual and predicted visual-motor integration and neurodevelopmental index were
normal when a cerebral oxygen saturation less than 45% and other risk conditions were avoided.
Conclusions: Neurodevelopmental performance was related to demographic, neonatal perioperative phys-
iologic, and later factors. Perioperative cerebral oxygenation assessed by near-infrared spectroscopy can
detect hypoxic-ischemic conditions associated with injury and reduced neurodevelopmental performance
and was the most significant physiologic factor identified. These data suggest that efforts to avoid cerebral
hypoxia are likely to improve the outcomes in this high-risk population. (J Thorac Cardiovasc Surg
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The Journal of Thoracic and CarNeonates with hypoplastic left heart syndrome and its vari-
ants face life-threatening hemodynamic challenges before,
during, and after stage 1 palliation (S1P) by the Norwood
procedure, related to both patient-specific and treatment-
specific factors.1-3 Survival has improved with advances in
perioperative techniques, but perioperative mortality
remains significant,4 with neurodevelopmental (ND) out-
comes less than normal in survivors.5-8 Mitigation of
perioperative hypoxic-ischemic risk has been attributed to
intensivemonitoring and pharmacologic strategies to controldiovascular Surgery c Volume 146, Number 5 1153
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
CVP ¼ central venous pressure
DHCA ¼ deep hypothermic circulatory arrest
MRI ¼ magnetic resonance imaging
ND ¼ neurodevelopmental
NDI ¼ neurodevelopmental index
NIRS ¼ near-infrared spectroscopy
rSO2C ¼ regional cerebral oxygen saturation
S1P ¼ stage 1 palliation
SaO2 ¼ arterial oxygen saturation
SD ¼ standard deviation
SvO2 ¼ venous oxygen saturation
VMI ¼ visual-motor integration
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Dhemodynamic responses and improve systemic oxygen
delivery.9-13 Beyond survival, we have shown that neonatal
perioperative hemodynamics, as assessed by venous
oxygen saturation (SvO2), can predict the ND outcome at
age 4 years,14 presumably because the SvO2 from the supe-
rior vena cava is a proxy measure of cerebral oxygena-
tion.15,16 We hypothesized that a more direct measure of
brain oxygenation might show a stronger relationship to
conditions that cause injury and functional impairment.
Near-infrared spectroscopy (NIRS) provides a measure of
organ-specific venous-weighted oxyhemoglobin satura-
tion.17,18 Monitoring of brain oxygenation by NIRS is now
practical, with accuracy and validity, and comparative data
are available for normal and perioperative states for adults
and neonates.19-26 Cerebral NIRS monitoring allows
continuous, quantitative, and noninvasive detection of
conditions of cerebral hypoxic risk.27-30 Previous work has
identified a high risk of cerebral desaturation in the early
postbypass and intensive care unit period14,28,31,32 and
evidence of a relationship between cerebral hypoxia detected
by NIRS and the occurrence of brain injury detected by
imaging and other measures in the early postoperative
period.33-36 In the present report, we tested the hypothesis
that early perioperative cerebral hypoxia contributes to
reduced ND performance by examining the relationship
between cerebral oxygenation, as assessed by NIRS after
S1P, andmeasures of NDoutcome assessed at age 4 to 5 years.METHODS
Patients
All neonates undergoing S1P had their perioperative hemodynamic data
recorded in standardized format in a prospective database, including SvO2
since 1996, and including cerebral and somatic NIRS starting in 2002.
Patients with hypoplastic left heart syndrome who had undergone an initial
staged reconstruction using a standardized perioperative management strat-
egy with antegrade cerebral perfusion and intraoperative and postoperative
cerebral NIRS monitoring were eligible for ND testing at 4 to 6 years of1154 The Journal of Thoracic and Cardiovascular Surage as a part of an institutional review board-approved study at the Children’s
Hospital of Wisconsin. Sequential patients who had received postoperative
NIRSmonitoring constituted the operative cohort, and all whohad completed
a ND assessment by September 2009 were included in the primary analysis.
Protocols for neonatal hemodynamic data collection, phenoxybenz-
amine administration, and ND assessment were followed. The preoperative
factors extracted for the present analysis included gestational age and
weight at birth, age and weight at S1P, gender, anatomic subtype, prenatal
diagnosis, the presence of associated abnormalities or syndrome, and the
use of preoperative mechanical ventilation or inotropes. A preoperative
high-risk status was defined as gestational age younger than 35 weeks,
birthweight less than 2.5 kg, or the presence of noncardiac anomalies.
The perioperative variables included cardiopulmonary bypass (CPB)
time, circulatory arrest, antegrade cerebral perfusion, shunt type (modified
Blalock-Taussig shunt vs right ventricle to pulmonary artery shunt), and the
use of extracorporeal membrane oxygenation. Other factors included the
need for manual cardiopulmonary resuscitation during the initial hospital-
ization, interstage events (after discharge from S1P to stage 2), and the
occurrence of a neurologic event after S1P.
Clinical Management
The neonatal perioperative management strategies have been previously
described9,13,26,37,38 and included preoperative stabilization with
prostanoids, intraoperativehigh-dose opioidand isoflurane-balanced anesthe-
sia, aprotinin, high-flow CPB to 18C to 20C using pH-stat blood gas man-
agement, and arch reconstruction with deep hypothermic antegrade cerebral
perfusion by way of an innominate artery shunt at 50 mL/kg/min flow with
minimal circulatory arrest. Phenoxybenzamine 0.25mg/kgwas administered
to all patients receiving CPB.37,39 The postoperative hemodynamic targets
included the mean arterial pressure greater than 45 mm Hg, central venous
pressure (CVP) 8 to 12 mm Hg, arterial oxygen saturation (SaO2) greater
than 75%, superior vena cava SvO2 greater than 50%, and cerebral oxygen
saturation (rSO2C) greater than 50%. Strategies to achieve these targets
included delayed sternal closure, maintenance of normothermia (36.2-
37.8C) using a servocontrolled warmer, sedation, and mechanical
ventilation with adjustment of arterial carbon dioxide tension, transfusion
of red blood cells to maintain hematocrit greater than 40%, and continuous
infusions of milrinone, epinephrine, and norepinephrine, as necessary.
Neither buffer nor hyperventilation was used to adjust blood pH.
Physiologic Assessment
The hemodynamic data included SaO2 (Masimo SET algorithm,
Masimo Corp, Irvine Calif), SvO2 (4F Oxycath, Abbott Laboratories,
Abbott Park, Ill) placed in the superior vena cava at S1P, invasive mean
arterial pressure, and CVP (from the umbilical vein or common atrial
line), all acquired by a standard multiparameter monitor (Solar, GEHealth-
care, Milwaukee, Wis). The cerebral oxygen saturation was obtained from
a right-midline forehead sensor and somatic/renal saturation from the
T12-L2 somatic region using a dual-light path, continuous-wave, NIRS
device (INVOS 5100A/B with a pediatric sensor, Somanetics Inc, Troy,
Mich).31 These measures were continuously monitored and recorded at
hourly intervals using a standardized clinical flowsheet for the first 48 hours
after S1P. A laboratory assessment of the arterial and venous blood gases,
including arterial carbon dioxide tension, hydrogen ion log concentration
(pH), standard base excess, and hemoglobin concentration, was obtained
at clinically indicated intervals and included in the physiologic database,
with linear interpolation of missing values. The derived physiologic vari-
ables were computed using standard formulas (including the cerebral arte-
riovenous saturation difference: DarSO2C ¼ SaO2  rSO2C).31,34
Neurodevelopment Assessment
A ND test battery was administered by a single developmental psychol-
ogist under controlled conditions. The visual-motor integration (VMI)gery c November 2013
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Dabilities are important for the development of higher level integrative skills,
such as handwriting, reading, written language, andmath achievement.40-42
Previous work has shown that visual-motor skills are at risk of impairment
in children with complex congenital heart disease.38,43-46 From these
studies, including our previous finding of a strong relationship between
low superior vena cava saturation during S1P and later visual-motor perfor-
mance,14 the Beery-Buktenica Developmental Test of Visual Motor Inte-
gration was chosen as the primary outcome measure in the present study.
Additional dimensions assessed included measures of cognitive perfor-
mance (Wechsler Preschool and Primary Scale of Intelligence III Matrix
Reasoning Score), attention (Developmental NEuroPSYchological Assess-
ment Visual Attention Scale), and language (Differential Ability Scales II
Naming Vocabulary Test). A composite neurodevelopmental index (NDI)
was constructed using equally weighted measures from all 4 dimensions
after normalization to a mean standard deviation (SD) of 100 15. Stan-
dardized scores on the VMI and NDI were classified as normal (>85), low
(1 SD or<85), and abnormal (2 SD or<70). The parental assessment
included maternal performance on the Wechsler Abbreviated Intelligence
Test. The distance to the hospital and family income were estimated by
the zip code of residence.
Statistical Analysis
Descriptive data, measures, and derived parameters are expressed as the
mean SD if normally distributed and as the median interquartile range
if not, and the 5% to 95% percentiles or range. The results of estimation
are expressed as the mean standard error, with 95% confidence intervals.
Statistical comparisons of continuous measures were performed using
analysis of variance for parametric measures, or the Kruskal-Wallis test
on ranks or the Kolmogorov-Smirnov test on distributions for nonparamet-
ric measures. Comparisons of proportions were done using the chi-square
likelihood ratio test or the Fisher exact test, as appropriate. Statistical com-
parisons of independent measures repeated over timewere performed using
summary statistics, the between factor in analysis of variance for repeated
measures, or the generalized maximum-likelihood time-series regres-
sion.47 Summary measures for cerebral oxygenation included the 48-
hour average, hours under cutpoints and area under curve, for thresholds
of 45%, 50%, and 55%.48 To assess the potential ascertainment bias,
the demographic, treatment, and physiologic measures were compared be-
tween the subgroups that did or did not complete ND testing. To evaluate
the factors related to ND outcome, subgroups with low or abnormal versus
normal ND performance were compared with univariate followed by mul-
tivariate tests, and regression techniques were used across the entire tested
cohort. Because previous work has demonstrated a nonlinear relationship
between cerebral saturation and indexes of neurologic injury, both linear
and nonlinear relationships were explored, using second- and third-order
fractional polynomials and bilinear (breakpoint) regression analysis. Statis-
tically significant physiologic parameters were then stratified at clinically
appropriate thresholds to assess nonlinear relationships and entered into
multivariate models using the between-patient estimator for outcome.
The patient and treatment demographic factors were included in multivar-
iate models of ND performance versus physiologic measures, using step-
wise techniques with P< .2 for inclusion,49-51 and with constraints for
selection of important biologic parameters.52,53 All tests were conducted
as 2-tailed and considered statistically significant at P<.05 after adjust-
ment for repeated measures within patient panels by variance correction
and for multiple comparisons by Tukey’s honestly significant difference
or Bonferroni’s method. All analyses were performed with Stata, version
11 (StataCorp 2009, College Station, Tex).RESULTS
Of the 51 patients in the operative cohort, stage 1 opera-
tive survival (30-day or discharge) was 48 of 51 (94%), and
cumulative survival (to the time of study) was 44 of 51The Journal of Thoracic and Car(86%) at 7.1  1.0 years (range, 5.1-8.9 years). ND testing
was completed in 21 patients (41% of total and 48% of sur-
vivors). The demographic and treatment parameters are
summarized in Table 1, for the entire operative cohort and
the subgroup that completed ND testing. No significant dif-
ferences were found between the tested and nontested sub-
groups, other than nonsurvivors requiring more time on
extracorporeal membrane oxygenation. The incidence of
preoperative high-risk status (prematurity, low birth weight,
or other noncardiac anomalies) was 13 of 51 (25%) overall,
3 of 7 (43%) in nonsurvivors, and 3 of 21 (14%) in tested
patients (P ¼ NS). The physiologic parameters are summa-
rized in Table 2. The only differences between the tested
and nontested subgroups were attributable to the duration
of extracorporeal membrane oxygenation.
Themean age at testingwas 56.3 5.5months (range, 48-
66 months). Performance of the tested cohort on the Beery-
Buktenica VMI test was 93.4 14 (range, 51-114), less than
the general population mean of 100 (P¼ .043). Only 1 of 21
patients (4.7%) had an abnormal VMI (<70), and 3 (14.2%)
had a low performance (<85), frequencies not different from
the expected norm. Performance on the Wechsler Preschool
and Primary Scale of Intelligence III Matrix Reasoning
Score (cognition) and Differential Ability Scales II Naming
Vocabulary Test (language) were normal, performance on
the Developmental NEuroPSYchological Assessment-
Visual Attention Scale (attention) was above normal, and
the composite NDI was normal at 97.6  9.6 (range,
71-109). These results are summarized in Table 3.
The average rSO2C in the first 48 postoperative hours
after S1P was 67.1  8.3, lower in patients who demon-
strated low or abnormal VMI performance compared with
the rest of the tested cohort (rSO2C 63.6  8.1 vs
67.8  8.1, P ¼ .026; Figure 1). The low-performing pa-
tients also spent more time with a rSO2C less than the
threshold of 55% and 45% (Table 4). During the first 48
postoperative hours, the rSO2C was consistently lower in
patients with a low performance, the SaO2 was lower during
the first 24 hours, and the mean arterial blood pressure was
not different (Figure 2). Other measures related to oxygen
delivery, including somatic/renal rSO2R, SvO2, and arterial
partial pressure of carbon dioxide, were not different
between the subgroups.
The 21patientswithND testing had a total of 1008hours of
physiologic data from the post-S1P period available for anal-
ysis (Table 5).Only rSO2CandSaO2weredifferent onunivar-
iate analysis between the low or abnormal and normal VMI
subgroups. The rSO2C, SaO2, and cerebral arterial-regional
saturation difference (DarSO2C) were related to VMI in non-
linear multivariate models (Figure 3). The mean arterial
blood pressure, CVP, hemoglobin concentration, and blood
gas parameters were not significant in either analysis.
Two children had discrete and clinically evident neuro-
logic events that occurred after their initial hospitalizationdiovascular Surgery c Volume 146, Number 5 1155
TABLE 1. Population characteristics, according to neurodevelopmental testing and cumulative survival status
Characteristic Overall Nonsurvivors
ND tested
No Yes
Patients (n) 51 (100) 7 (14)* 23 (45) 21 (41)
Age at S1P (d) 7.9  8.2 9.5  5.3 8.6  11.8 6.5  2.2
Weight at S1P (kg) 3.4  0.5 3.3  0.4 3.4  0.6 3.4  0.5
Female gender (n) 17 (33) 3 (43) 9 (39) 5 (24)
Gestational age (wk) 38.3  1.3 37.7  1.4 38.5  1.3 38.1  1.3
Prematurity (<37 wk) (n) 5 (9) 1 (17) 2 (6) 2 (9)
Prenatal diagnosis (n) 29 (57) 4 (57) 15 (65) 10 (48)
Preoperative high-risk status 13 (25) 3 (43) 7 (30) 3 (14)
Distance (ZIP code of residence, miles) 81  87 114  120 83  80 66  63
Income (ZIP code of residence, K$) 50  27 39  22 48  17 52  37
30-Day survival (n) 48 (94) 4 (57)* 23 (100) 21 (100)
Preoperative mechanical ventilation (n) 34 (66) 4 (57) 15 (65) 15 (70)
Preoperative inotropic support (%) 22 (43) 4 (57) 9 (39) 9 (43)
Aortic atresia (%) 25 (49) 5 (57) 11 (52) 9 (43)
Ascending aortic diameter (mm) 3.7  1.7 2.8  1.0 3.5  1.8 4.2  1.6
Morphologic LV dominance (%) 7 (14) 2 (29) 3 (13) 2 (9)
RV-PA conduit procedure (%) 20 (39) 5 (71) 9 (39) 6 (29)
Length of initial hospitalization (d) 44.1  31.8 63.6  32.5 46.7  37.9 34.7  19.6
Oral feeding at discharge (n) 19 (37) 3 (43) 9 (39) 7 (33)
Interstage monitoring (n) 43 (84) 4 (57)y 20 (87) 19 (90)
Interstage monitoring event (n) 24 (57) 2 (50) 9 (45) 11 (52)
ECMO use, patients (n) 4 (16) 2 (28) 1 (6) 1 (5)
ECMO use, total hours (% of 48) 166 (7) 89 (27)* 45 (4) 32 (3)
CPR performed (n) 4 (8) 2 (28) 1 (4) 1 (5)
Stroke after S1P (n) 3 (6) 0 (0) 1 (4) 2 (9)
Data are n (%) or mean  SD. No differences observed between subgroups, except for lower early survival in cumulative nonsurvivor subgroup. ND, Neurodevelopment;
S1P, stage 1 palliation; LV, left ventricular; RV-PA, right ventricle to pulmonary artery; ECMO, extracorporeal membrane oxygenation; CPR, cardiopulmonary resuscitation.
*P<.005, different from other groups by chi-square test. yP<.05, different from other groups by chi-square test.
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D(both embolic strokes, one after prestage 2 catheterization
and one after Fontan palliation). These 2 children had obvi-
ous motor impairment at testing and performed signifi-
cantly more poorly on VMI testing than the other patients
in the tested cohort. No difference was seen in the mean
hourly weighted rSO2C between patients who did or did
not experience late stroke (67.3  5.6 vs 67.1  8.5,
P ¼ NS). Excluding the 2 patients with late events, the 19
patients in the no-stroke subgroup demonstrated VMI per-
formance that was not different from normal; no patients
had abnormal VMI (<70), and 2 had low VMI (70-84), fre-
quencies not different from expected in a normal popula-
tion. In the no-stroke subgroup, the differences in rSO2C
between patients with low and normal VMI was larger
(rSO2C, 59.4  5.0 vs 68.2  4.8; P ¼ .026). With or with-
out adjustment for the occurrence of later stroke, a low VMI
was related to hourly measures of rSO2C less than 55% and
45% (P ¼ .003 for trend; Table 6).
Patientswhohad anyhourly rSO2C less than45% (extreme
desaturation) performed more poorly on VMI (79.5 9.1 vs
94.8  13.8, P ¼ .063) and composite ND measures
(87.6  9.9 vs 98.5  9.2, P ¼ .094). These differences
reached statistical significance in patients without stroke
(VMI, 79.5  9.2 vs 97.5  9.8, P ¼ .025; NDI, 87.6  9.91156 The Journal of Thoracic and Cardiovascular Survs 100.1  6.7, P ¼ .028). These 2 factors (area under the
curve of rSO2C<45% and occurrence of stroke) determined
41% of the variance in VMI and 33% of the variance in NDI
(Table 7). The 4 patients identified by these 2 acquired factors
had significantly worse ND performance than those without
cerebral desaturation or stroke (VMI, 75.8  17.0 vs
97.5  9.8, P< .005; NDI, 86.7  13.2 vs 100.1  6.7,
P<.01).
Nonlinear (breakpoint) univariate regression of rSO2C
against the 4 ND tests and the composite NDI revealed
rSO2C thresholds in the 45% to 55% for relationships to
VMI, Matrix Reasoning Score, Naming Vocabulary Test,
and composite NDI performance measures. The regressions
were significant for VMI, Matrix Reasoning Score, and
composite NDI. These results are summarized in Table 8.
The results were not significantly altered by exclusion of
patients with stroke, nor were they dependent on values of
rSO2C less than 45%.
Multiple regression of neonatal demographic and hemo-
dynamic parameters against childhood VMI performance
revealed that hourly rSO2C, SaO2, age at S1P, weight at
S1P, CPB time, deep hypothermic circulatory arrest
(DHCA) time, and presence of post-S1P stroke produced
the best model that explained an important amount of thegery c November 2013
TABLE 2. Postoperative physiologic measures in all 51 patients and
stratified by neurodevelopmental testing
Characteristic Overall Nonsurvivors
ND tested
No Yes
Patients (n) 51 (100) 7 (14) 23 (45) 21 (41)
rSO2C (%) 67.6  8.3 71.1  8.4 66.9  7.9 67.1  8.3
rSO2R (%) 78.8  7.2 80.9  6.2 77.4  8.0 79.6  6.3
SaO2 (%) 84.5  5.5 87.8  6.7 83.9  5.1 84.1  5.1
SvO2 (%) 64.3  9.3 68.5  11.0 63.3  9.2 64.1  8.7
BP (mm Hg) 51.8  5.9 51.0  5.4 51.0  6.5 52.9  5.1
CVP (mm Hg) 9.8  2.3 9.1  2.1 10.0  2.5 9.7  2.0
HR (beats/min) 173  16 171  21 172  15 174  16
pCO2 (mm Hg) 44.3  7.0 49.5  9.4* 44.4  6.7 42.9  6.2
pO2 (mm Hg) 52.7  27 73.8  48 50.8  25 50.3  21
Base excess
(mEq/L)
0.45  4.6 0.27  5.0 0.12  4.4 0.87  4.7
Hb (g/dL) 15.7  1.6 15.3  1.8 15.8  1.5 15.8  1.6
Sa-vO2 (%) 19.9  8.6 17.7  9.2 20.4  8.2 20.0  8.7
Da-vO2 (cm
3/dL) 4.3  1.9 3.7  2.0 4.5  1.8 4.2  1.9
DarSO2C (%) 16.8  7.9 16.7  8.8 16.7  7.4 16.9  8.0
DarSO2R (%) 5.7  7.1 6.9  6.5 6.1  7.5 4.6  6.8
Data presented as n (%) ormean SD.Complete data available for 2106 of 2448 hours
of monitoring during first postoperative 48 hours. No differences were observed
between tested and nontested subgroups. The minor difference observed in nonsurvi-
vors was attributable to measures obtained during extracorporeal membrane oxygena-
tion support.ND, Neurodevelopment; rSO2C, cerebral oxygen saturation; rSO2R, renal
oxygen saturation; SaO2, arterial oxygen saturation; SvO2, venous oxygen saturation;
BP, mean arterial blood pressure; CVP, central venous pressure; HR, heart rate;
pCO2, partial pressure of carbon dioxide; pO2, partial pressure of oxygen;Hb, hemoglo-
bin;Sa-vO2, arterial-venous saturation difference;Da-vO2, arterial-venous oxygen con-
tent difference; DarSO2C, cerebral arterial-regional saturation difference; DarSO2R,
renal arterial-regional saturation difference. *P< .005, different from other groups
by analysis of variance.
FIGURE 1. Distribution of hourly cerebral saturation (rSO2C) in patients
with normal and low performance on visual-motor integration (VMI) test-
ing. Average values and distributions were lower in patients with low VMI
scores (P<.05). See text for details.
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Dvariance observed in VMI (R2 ¼ 0.53, P<.001; Table 9).
The best-subset algorithm selected stroke, rSO2C, CPB
time, and DHCA time as the most efficient model of factorsTABLE 3. Neurodevelopmental assessment results in all 21 tested
patients
ND test
dimension Raw score Normalized score
P value
(compared
with normal)
VMI 93.4  14.0 93.4  14.0 (53-114) <.05*
Cognitive
(WPPSI-MRS)
9  2.9 95.0  14.5 (65-125) NS
Attention
(NEPSY-VAS)
11.4  1.9 106.9  9.7 (85-120) <.005*
Language
(DAS-NVT)
46.6  8.8 94.9  13.2 (72-117) NS
Composite score
(NDI)
97.6  9.6 (71-109) NS
Data presented as mean  standard deviation (range). Composite NDI scores were
normal compared with age-based standards. Performance was less than normal for
VMI, above normal for attention, and not different from normal for cognitive and lan-
guage dimensions. See text for details. ND, Neurodevelopmental; VMI, visual-motor
integration; WPPSI-MRS, Wechsler Preschool and Primary Scale of Intelligence III
Matrix Reasoning Score; NS, not significant; NEPSY-VAS, Developmental NEuro-
PSYchological Assessment Visual Attention Scale; DAS-NVT, Differential Ability
Scales II Naming Vocabulary Test; NDI, neurodevelopmental index. *Different
from population normal (100  15) by analysis of variance.
The Journal of Thoracic and Carrelated to VMI (R2 ¼ 0.50, P<.001). When controlling for
factors of age and weight at S1P, CPB time, and DHCA time
at their average values and the absence of post-S1P stroke,
the predicted VMI was normal with an hourly rSO2C
greater than 55% (Figure 4). When adjusted for all param-
eters at the low-risk conditions (term gestation, age at S1P
of 6 days, CPB time of 120 minutes, DHCA time of 10 min-
utes, and no post-S1P stroke), the predicted VMI was
normal until a breakpoint at an rSO2C of less than 45%
(Table 10).
DISCUSSION
The composite ND performance of this cohort was nor-
mal, but the tests of VMI were slightly less than the popu-
lation mean, consistent with other reported cohorts with
hypoplastic left heart syndrome.7,8,14,38,54,55 Our primary
finding was that low brain oxygenation, as measured by
NIRS in the early post-S1P period, was a risk factor for
reduced ND performance in childhood. We have previously
reported,14 using a similar study design, that SvO2 obtained
from the superior vena cava after S1P, which is highly deter-
mined by cerebral oxygenation,15,56 was related to the ND
outcome in early childhood. The results from the present
study have corroborated those findings using a more
direct and noninvasive measure of cerebral oxygenation.
Whether the low brain oxygenation measured during the
first 48 postoperative hours is the actual cause of brain
injury or is a marker for infants with reduced physiologic re-
serve and an ongoing risk of reduced cerebral oxygenation
in the post-S1P period57,58 could not be determined from the
present study; both relationships could be true. During the
4-year period between neonatal palliation and ND evalua-
tion we have reported, multiple pathophysiologic processes,
other than early brain hypoxia, can influence braindiovascular Surgery c Volume 146, Number 5 1157
TABLE 4. Measures of cerebral oxygenation during 48 hours after S1P stratified by VMI results
Cerebral oxygenation measure Overall (n ¼ 21) Normal VMI (85; n ¼ 18) Low VMI (<85; n ¼ 3)
rSO2C (%)
48-Hour average 67.1  8.3 (40-85) 67.8  8.1 (42-85) 63.6  8.1 (40-81)*
48-Hour minimum 55  7.2 (40-68) 55.3  5.7 (42-68) 53.3  12 (40-63)
rSO2C (h)
<55% 3.2  7.3 2.5  6.2 7.7  13.3y
<50% 0.7  2.3 0.6  2.4 1.3  2.3
<45% 0.3  0.9 0.2  0.7 1.0  1.7y
rSO2C AUC
<55% 12.6  30 (0-104) 9.7  27 (0-104) 30  52 (0-90)
<50% 3.2  10 (0-40) 2.4  9 (0-40) 8.3  14 (0-25)
<45% 0.71  2.3 (0-8) 0.4  1.6 (0-7) 2.7  4.6 (0-8)z
Data presented as mean  standard deviation (range). Patients with low VMI had lower average rSO2C, more hours spent at rSO2C<45%, and larger area under curve of rSO2C
<45%. S1P, Stage 1 palliation; VMI, visual-motor integration; rSO2C, cerebral oxygen saturation; AUC, area under the curve. *P<.05, different from subgroup with normal VMI,
repeated measures analysis of variance. yP<.05, different from subgroup with normal VMI, likelihood-ratio test. zP<.05, different from subgroup with normal VMI, 1-way
analysis of variance.
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Ddevelopment and the occurrence of injury, including, but
not limited to, patient- and center-specific management
strategies,8 subsequent procedures, prolonged hospitaliza-
tions, and intercurrent events such as the 2 embolic strokes
identified.
The finding that early measures of brain oxygenation have
persistent effect despite multiple intervening events is evi-
dence for the importance of hypoxic-ischemic mechanisms
contributing to cerebral injury and offers the opportunityFIGURE 2. Temporal changes in early physiologic measures after stage 1 pal
testing in childhood. In patients with low performance on VMI testing, cerebra
arterial oxygen saturation (SaO2) lower, and heart rate (HR) higher during firs
superior vena cava oxygen saturation (SvO2), mean arterial blood pressure (M
pressure of carbon dioxide (PaCO2). ns, Not significant; ANOVA, analysis of v
1158 The Journal of Thoracic and Cardiovascular Surfor treatment and prevention. In the care of the present pa-
tients, interventions to maintain rSO2C greater than 50%
were a part of the perioperative management strategy and,
thus, might have reduced the occurrence of cerebral
hypoxia-ischemic injury, as suggested in an early report of
a reduced occurrence of postoperative neurologic findings
with active management of perioperative cerebral rSO2C.
59
Compared with our previously reported patient cohort man-
aged without NIRS, the superior vena cava SvO2 in theliation (S1P) according to performance on visual-motor integration (VMI)
l saturation (rSO2C) was consistently lower during 48 postoperative hours,
t 24 hours. No differences were seen in somatic/renal saturation (rSO2R),
ABP), central venous/common atrial pressure (CVP), or arterial partial
ariance.
gery c November 2013
TABLE 5. Postoperative physiologic parameters (from 1008 hours
total monitoring in 21 patients) stratified by VMI results
Parameter
Overall
(n ¼ 21)
Normal VMI
(85; n ¼ 18)
Low VMI
(<85; n ¼ 3)
rSO2C (%) 67.1  8.3 67.8  8.1 63.6  8.1*
rSO2R (%) 79.6  6.3 79.7  6.7 79.3  3.9
SaO2 (%) 84.1  5.1 84.7  4.8 80.3  5.4*
SvO2 (%) 64.1  8.7 64.0  8.8 64.2  7.8
BP (mm Hg) 52.9  5.1 52.8  5.1 53.3  4.9
CVP (mm Hg) 9.7  2.0 9.8  2.0 9.3  1.7
HR (beats/min) 174  16 174  16 178  11
pCO2 (mm Hg) 42.2  6.0 42.2  5.9 42.1  6.2
pO2 (mm Hg) 46.9  5.2 47.3  5.2 44.4  4.7
Base excess (mEq/L) 1.5  4.3 1.8  4.4 0.4  3.4
Hb (g/dL) 15.9  1.4 15.9  1.5 15.9  1.2
Sa-vO2 (%) 20.0  8.7 20.6  8.4 16.2  9.5
Da-vO2 (cm
3/dL) 4.4  1.8 4.4  1.9 3.5  2.1
DarSO2C (%) 16.9  8.0 17.0  7.9 16.7  8.8
DarSO2R (%) 4.6  6.8 5.4  6.7 1.1  6.1
Data presented as mean standard deviation. VMI,Visual-motor integration; rSO2C,
cerebral oxygenation saturation; rSO2R, renal oxygen saturation; SaO2, oxygen satu-
ration; SvO2, venous oxygen saturation; BP, mean arterial blood pressure; CVP, cen-
tral venous pressure; HR, heart rate; pCO2, partial pressure of carbon dioxide; pO2,
partial pressure of oxygen;Hb, hemoglobin; Sa-vO2, arterial-venous saturation differ-
ence;Da-vO2, arterial-venous oxygen content difference;DarSO2C, cerebral arterial-
regional saturation difference;DarSO2R, renal arterial-regional saturation difference.
*P<.05, different from subgroup with normal VMI, repeated measures analysis of
variance.
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Dpresent cohort was significantly greater (62.6  7.88 vs
54.4  7.85, P<.01) and greater than the SvO2 threshold
for central nervous system injury.14 Likewise, the occurrence
of VMI in the abnormally low range (<70) was lower in the
present cohort than in the previous cohort (1/21 vs 3/18,
P ¼ .067; 0/19 vs 3/18, P< .03, excluding late strokes).
The findings within each cohort suggest that hypoxic-
ischemic injury remains a threat to the ND potential of these
patients. Comparative findings between cohorts suggest that
avoidance of cerebral hypoxia by active management to
avoid low rSO2C can improve outcome.
The average rSO2C was not different in patients with or
without the later occurrence of stroke; therefore, it is not
likely that changes in early perioperative cerebral perfusion
influenced the likelihood of later stroke, especially consider-
ing the acute embolic mechanism of these events. These pa-
tients had significantly reduced performance onVMI testing,
and their inclusion in the analysis complicated, but did not
obscure, the relationship between themeasured rSO2Cvalues
and laterNDperformance, again emphasizing the importance
of early global hypoxic-ischemic mechanisms of injury.
The finding of a nonlinear relationship between rSO2C
and VMI performance was consistent with both our previ-
ous report and other clinical and experimental studies that
showed threshold effects for the dose hypoxia-ischemic
conditions on cerebral injury. In normothermic ischemia
models using middle cerebral artery occlusion, pixel map-
ping the resulting continuous range of cerebral blood flowsThe Journal of Thoracic and Carto areas of biochemical and histologic neuronal injury al-
lows the creation of probabilistic models of injury accord-
ing to the reduction on blood flow and oxygen delivery.60
These models consistently find a threshold effect for injury,
with no injury in regions with cerebral blood flow and oxy-
gen delivery indexes greater than 50% of normal, with
reversible injury in regions with flow indexes from 25%
to 50% of normal, and with irreversible injury in regions
with flow indexes less than 20% of normal. In piglet models
of brain metabolism during acute hypoxia-ischemia moni-
tored by NIRS, a threshold for lactate production occurred
with rSO2C less than 50%, and progressive neuronal dys-
function culminating in cellular death at rSO2C less than
30%.29 These thresholds occurred at NIRS-derived cerebral
arteriovenous differences that were doubled or tripled, cor-
responding to cerebral oxygen delivery indexes that were
50% and 33% of normal, respectively. The rSO2C thresh-
olds in the 45% to 55% range that we observed would cor-
respond to a reduction in cerebral blood flow or oxygen
delivery to the range found to induce injury in these models.
Although the relationship between the time-below-
threshold and injury is complex, piglet data suggest that 1
to 2 hours of normothermic hypoxia to an rSO2C of 35%
will induce acute histologic injury.61 These studies have
corroborated our findings of both the degree and the
duration of cerebral desaturation related to low ND perfor-
mance. We emphasize that the thresholds for rSO2C in
the 45% to 55% range were determined from measures
that persisted for at least 1 hour in patients with reduced per-
formance (Table 4). Automated algorithms that report nadir
values might capture transient desaturations that have very
small areas under curve and would be less likely to be pre-
dictive of, or result in, cerebral injury, especially with active
clinical management in response to desaturation.62
The rSO2C, a very close approximation of the cerebral
oxygen supply-demand balance, was the physiologic param-
eter that was most strongly related to VMI and NDI in mul-
tivariate models. The cerebral oxygen supply is determined
by perfusion pressure (mean arterial blood pressure minus
CVP), SaO2, hemoglobin concentration, and cerebrovascu-
lar resistance, modifiable by partial pressure of carbon
dioxide. The cerebral metabolic rate is determined by tem-
perature and brain activity, modifiable by opioids and benzo-
diazepines, respectively. Changes in cerebral autoregulation
after profound hypothermic bypass27,30,31,63-65 are likely to
make the brain more vulnerable to supply side deficiencies
and thus increasing the SaO2, hemoglobin, and partial
pressure of carbon dioxide are particularly useful in the
post-S1P period to increase cerebral oxygenation. These
changes in autoregulation might explain our observation of
a significant positive relationship of SaO2 and an apparent
optimum in cerebral arterial-regional saturation difference
(DarSO2C) (Figure 3), and underlie the observation of low
cerebral oxygen extraction in neonates after birth asphyxia.34diovascular Surgery c Volume 146, Number 5 1159
FIGURE 3. Fractional polynomial models of physiologic parameters versus visual-motor integration (VMI) performance. Magnitude of effect of each
parameter estimated as difference in nonoverlapped confidence intervals of model VMI. Significant effects are depicted as gray-shaded areas. CI, Confi-
dence interval; rSO2C, cerebral oxygen saturation; SaO2, arterial oxygen saturation; DarSO2C, cerebral arterial-regional saturation difference; BP, mean
arterial blood pressure; rSO2R, renal oxygen saturation; SavO2, arterial-venous saturation difference;DarSO2R, renal arterial-regional saturation difference.
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DAlthough impaired cerebral autoregulation makes cerebral
blood flow more pressure passive,31,66 manipulation of
blood pressure is particularly difficult after S1P because of
afterload-sensitive myocardial function and parallel circula-
tory anatomy,9,37,39 and maintaining high arterial SaO2 and
blood pressure does not always avoid a low rSO2C after
S1P.30,31,56,65 Likewise, in the present study, we did not
find evidence of a relationship between arterial blood
pressure and ND performance, although our average
arterial blood pressure was well above the reported lowerTABLE 6. Risk of low VMI (<85) progressively increased with lower hour
Cerebral oxygenation
(hourly rSO2C)
All tested patients (n ¼ 21)
Frequency (h) Risk of low VMI (<85)
<45% 7 0.43  0.21
46%-55% 80 0.29  0.08
56%-65% 265 0.18  0.04
>65% 542 0.13  0.02
Overall 894 0.16
Data presented as mean  standard deviation. Risk significantly increased with rSO2C<4
terstage neurologic event. VMI, Visual-motor integration; rSO2C, cerebral oxygen saturat
1160 The Journal of Thoracic and Cardiovascular Surlimit of autoregulation in newborns after cardiac surgery,67
and active manipulation of all supply-side (blood pressure,
partial pressure of carbon dioxide, hemoglobin concentra-
tion, arterial saturation) and demand-side factors (tempera-
ture, arousal, activity) was a part of standard perioperative
management to avoid low rSO2C.
The complexity of perioperative management strategies,
and the interaction of intraoperative factors on postopera-
tive cerebral hemodynamics, confounds the analysis of peri-
operative factors on outcomes. A study of brain injuryly rSO2C
Patients without stroke (n ¼ 19)
P value Frequency (h) Risk of low VMI (<85) P value
<.05* 7 0.43  0.21 <.05*
<.005* 80 0.29  0.08 <.005*
226 0.12  0.02
485 0.09  0.02
<.005y 798 0.12 <.005y
5% and 46%-55%, with and without exclusion of patients who experienced an in-
ion. *Risk different from overall. yChi-square test for trend.
gery c November 2013
TABLE 7. Linear models of neurodevelopmental outcomes (n ¼ 21) as function of postoperative cerebral desaturation and interstage stroke
Equation b-rSO2Cauc45 b-stroke Constant RMSE R
2 F P value (overall model fit)
VMI 2.5  1.1* 25.6  8.5* 97.6  2.75 11.4 0.411 6.29 <.005
Cognitive (WPPSI-MRS) 2.1  1.4 15.5  10.3 100.0  3.3 13.7 0.191 2.12 NS
Attention (NEPSY-VAS) 0.4  1.0 2.4  7.6 107.4  2.5 10.1 0.011 0.10 NS
Language (DAS-NVT) 2.0  1.2 14.2  9.3 97.7  3.0 12.5 0.194 2.17 NS
Composite score (NDI) 1.7  0.8* 14.4  6.2* 100.1  2.0 8.3 0.331 4.45 <.05
Model coefficients presented as b standard error. Measure of cerebral desaturation was area under curve less than threshold of 45% (rSO2Cauc45), and stroke was presence of
discreet later-stage embolic event; both factors were significant determinants of ND performance, explaining 41% of VMI variance and 33% of NDI variance. The constant in
each model was equal to the ND score in patients with neither rSO2C<45% nor interstage stroke. rSO2Cauc45, Cerebral desaturation was area under curve less than threshold of
45%; RMSE, root mean square error; VMI, visual-motor integration; WPPSI-MRS, Wechsler Preschool and Primary Scale of Intelligence III Matrix Reasoning Score; NS, not
significant;NEPSY-VAS,Developmental NEuroPSYchological Assessment Visual Attention Scale;DAS-NVT,Differential Ability Scales II Naming Vocabulary Test;NDI, neuro-
developmental index. *P<.05.
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Dmarkers on magnetic resonance imaging (MRI) after neona-
tal cardiac surgery with high-flow antegrade cerebral perfu-
sion and active management to avoid rSO2C less than 50%
did not find a relationship between newMRI lesions and the
duration of rSO2C less than 45%.
68 However, that study in-
cluded both single-ventricle and 2-ventricle surgical proce-
dures and noted a significant variation in the use of
aprotinin, which might be neuroprotective and does alter
the MRI findings.69 Although we would argue the undesir-
ability of any acquired abnormalities on any assessment of
brain structure or function, not all MRI lesions are ischemic
in origin or indicative of permanent injury; the relationship
between the postoperative MRI findings and later measures
of ND performance is complex.68,70-73 A follow-up report
of ND testing at 15 months55 found near-normal perfor-
mance on a variety of measures, without a relationship to
perioperative NIRS, although no rSO2C less than 45%
was observed. Additionally, their analysis did not separate
postoperative normothermic rSO2C measures from those
obtained during the intraoperative period of profound hypo-
thermia, which is likely to alter the critical rSO2C threshold
for injury while increasing the rSO2C
30,35,36,74,75 and thus
obscure the relationship to outcome. Multivariate models
consider additive risk constructs, and individual parameter
effects will be dependent on the magnitude of other
effects, especially in smaller study populations. Our
analysis, with control for some confounding factors in
a more homogeneous surgical population, does reveal anTABLE 8. Bilinear (breakpoint) univariate regression of cerebral oxygen
ND test
Breakpoint ± SE
(rSO2C%)
b-Coeffici
(slope vs r
VMI 56.9  2.4* 0.86 
Cognitive (WPPSI-MRS) 49.2  4.7* 1.52 
Attention (NEPSY-VAS) 55.8  42.2 0.04 
Language (DAS-NVT) 62.2  2.0* 0.78 
Composite score (NDI) 55.8  2.6* 0.60 
Breakpoint was rSO2C belowwhich a relationship between ND performance and cerebral s
the breakpoint, no relationship found with ND performance, meaning the slope was 0. A sig
were characterized. SE, Standard error; ND, neurodevelopmental; VMI, visual-motor integr
Reasoning Score; NEPSY-VAS, Developmental NEuroPSYchological Assessment Visual
NDI, neurodevelopmental index; rSO2C, cerebral oxygen saturation. *P<.001. yP<.05.
The Journal of Thoracic and Careffect of normothermic cerebral oxygenation on later ND
performance, probably related to perioperative hypoxic-
ischemic injury. During the study period, the patients
were treated using standard protocols for assessment and
treatment throughout the staged reconstruction, reducing
the variability in unmeasured confounders and, therefore,
allowing observation of significant relationships between
treatment variables and outcomes that could be obscured
in other studies.76,77
The present study had several limitations. The ND assess-
ment was completed in only 48% of the eligible cohort;
thus, ascertainment bias might have influenced these find-
ings. However, we found no differences in demographic
or physiologic parameters between the tested and nontested
groups (Tables 1 and 2) and that the distance from the study
center was the most common reason to decline testing. The
number of patients in the present analysis cohort was small,
and the range of physiologic parameters and ND outcome in
our cohort was narrow compared with previous cohorts. We
speculated that the exposure of patients to injurious degrees
of cerebral hypoxia might have been limited by
management targeting rSO2 greater than 50% as a part of
a cerebral goal-directed strategy, thereby reducing the inci-
dence of very low ND performance in the present cohort.
However, the persistence of a relationship between outcome
and rSO2C with relatively constrained global hemodynam-
ics only emphasizes the importance of cerebral oxygenation
as an influence on ND performance. Because multiplesaturation against later neurodevelopmental performance
ent ± SE
SO2C%)
Predicted score
(above breakpoint)
P value
(overall model fit)
0.37y 93 <.005
1.48 94
0.30 107
0.20* 96 <.005
0.30y 97 <.05
aturation was found, with b-coefficient characterizing slope of this relationship; above
nificant model fit signified that both the breakpoint and the slope below the breakpoint
ation;WPPSI-MRS,Wechsler Preschool and Primary Scale of Intelligence III Matrix
Attention Scale; DAS-NVT, Differential Ability Scales II Naming Vocabulary Test;
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TABLE 9. Regression model showing relationship of cerebral oxygen
saturation, physiologic and demographic variables to childhood VMI
standard score
Parameter
b-
Coefficient
± SE 95% CI t P value>jtj
rSO2C
(polynomial)%
0.11  0.04 0.01, 0.20 2.51 <.05
SaO2 84.6% 0.37  0.16 0.010, 0.030 2.35 <.05
Age at S1P 6.8 d 1.55  0.71 0.06, 3.04 2.17 <.05
Weight at
S1P 3.4 kg
14.2  3.8 19.5, 21.1 3.70 <.005
CPB time 171 min 0.12  0.04 0.20, 0.03 2.87 <.05
DHCA time 9 min 1.34  0.59 2.57, 0.10 2.26 <.05
Stroke (0/1) 23.6  8.7 33.2, 27.6 2.26 <.05
Constant 98.1  2.4 99.3, 99.7 41.4 <.001
Parameters referenced to mean value, producing constant term equal to mean pre-
dicted VMI. Factors for preoperative high-risk status (gestational age< 35 weeks,
birthweight < 2.5 kg, associated noncardiac anomalies), maternal intelligence
quotient, family income, BP, CVP, pCO2, and Hb rejected, with P > .2. Best
between-effects time-series model: R2 ¼ 0.53; P < .001. rSO2C
(polynomial) ¼ (rSO2C  67.3)  0.25 3 (rSO2C  67.3)2. VMI, Visual-motor in-
tegration; SE, standard error; CI, confidence interval; rSO2C, cerebral oxygen satura-
tion; SaO2, arterial oxygen saturation; S1P, stage 1 palliation; CPB, cardiopulmonary
bypass; DHCA, deep hypothermic circulatory arrest.
TABLE 10. Multivariate prediction of VMI from model using
categorical rSO2C (R
2 ¼ 0.54, P<.01)
Hourly rSO2C VMI (model ± SE) 95% CI
>75% 103.3  1.3 95.3-111.3
66-75% 99.9  0.8 92.0-108.0
56-65% 98.0  1.0 90.0-106.0
46-55% 92.2  1.8 84.2-100.2
45% 86.3  6.1* 78.3-94.4
Model run for low-risk conditions, defined as age at S1P of 6 days, weight of 3.4 kg,
cardiopulmonary bypass time of 120 minutes, deep hypothermic circulatory arrest
time of 10 minutes, and no post-stage 1 palliation stroke; under these conditions,
reduced VMI performance was predicted at rSO2C<45%, with normal VMI perfor-
mance predicted at 45%. VMI, Visual-motor integration; rSO2C, cerebral oxygen
saturation; SE, standard error; CI, confidence interval. *P<.01, different from 100.
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Dfactors affect the occurrence of, and recovery from, cerebral
injury, the postoperative normothermic thresholds for cere-
bral oxygenation found in the present study might be gener-
alizable only to patients treated with similar perioperative
strategies. The adoption of recent recommendations for
screening and ND assessment of children with complex
congenital heart disease will drive more generalizable anal-
yses in the future.78FIGURE 4. Multivariate model prediction of visual-motor integration
(VMI) from hourly cerebral saturation (rSO2C). Predicted VMI was signif-
icantly lower with rSO2C less than 55%. Predicted VMI was normal (not
different from 100) when hourly rSO2C was maintained at greater than
55%. Predicted VMI was normal with rSO2C greater than 45% and other
standard risk conditions were applied. See text for details. CI, Confidence
interval; SD, standard deviation.
1162 The Journal of Thoracic and Cardiovascular SurCONCLUSIONS
The findings from the present report provide evidence
that NIRS monitoring of brain oxygenation can help direct
programmatic and patient-specific treatment strategies to
detect, treat, and avoid conditions that contribute to cerebral
injury.79-81 Although some determinates of outcome are not
modifiable, management strategies that target brain
oxygenation can reduce the burden of injury that results
from cerebral hypoxia and contributes to ND impairment,
allowing more children to achieve more normal outcomes.References
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